D
Travere Therapeutics, Inc.
TVTX
$15.25
-$1.31-7.91%
D
Sell
11/4/2024Upgraded
Travere Therapeutics, Inc. (TVTX) was upgraded to D- from E+ on 11/4/2024 due to an increase in the valuation index, growth index and volatility index. Earnings per share increased from -$0.9085 to -$0.7047, EBIT increased 16.44% from -$67.05M to -$56.03M, and total revenue increased 16.23% from $54.12M to $62.9M.
Travere Therapeutics, Inc. (TVTX) was upgraded to D- from E+ on 11/4/2024 due to an increase in the valuation index, growth index and volatility index. Earnings per share increased from -$0.9085 to -$0.7047, EBIT increased 16.44% from -$67.05M to -$56.03M, and total revenue increased 16.23% from $54.12M to $62.9M.
E
Sell
5/11/2023Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to E+ from D- on 5/11/2023 due to a decline in the growth index, volatility index and total return index. Operating cash flow declined 48.46% from -$54.64M to -$81.12M, earnings per share declined from -$1.0307 to -$1.2663, and EBIT declined 16.34% from -$69.01M to -$80.29M.
Travere Therapeutics, Inc. (TVTX) was downgraded to E+ from D- on 5/11/2023 due to a decline in the growth index, volatility index and total return index. Operating cash flow declined 48.46% from -$54.64M to -$81.12M, earnings per share declined from -$1.0307 to -$1.2663, and EBIT declined 16.34% from -$69.01M to -$80.29M.
D
Sell
3/14/2023Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 3/14/2023 due to a decline in the growth index, solvency index and valuation index. Debt to equity increased from 3.77 to 8.87, operating cash flow declined 38.24% from -$39.53M to -$54.64M, and the quick ratio declined from 3.96 to 3.28.
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 3/14/2023 due to a decline in the growth index, solvency index and valuation index. Debt to equity increased from 3.77 to 8.87, operating cash flow declined 38.24% from -$39.53M to -$54.64M, and the quick ratio declined from 3.96 to 3.28.
D
Sell
2/23/2023Upgraded
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
D
Sell
2/8/2023Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 2/8/2023 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from 2.42 to 3.77, and the quick ratio declined from 4.58 to 3.96.
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 2/8/2023 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from 2.42 to 3.77, and the quick ratio declined from 4.58 to 3.96.
D
Sell
5/31/2022Upgraded
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index.
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index.
D
Sell
5/13/2022Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 5/13/2022 due to a decline in the solvency index, growth index and total return index. Debt to equity increased from 0.76 to 1.82, operating cash flow declined 105.83% from -$26.88M to -$55.32M, and earnings per share declined from -$0.837 to -$1.2034.
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 5/13/2022 due to a decline in the solvency index, growth index and total return index. Debt to equity increased from 0.76 to 1.82, operating cash flow declined 105.83% from -$26.88M to -$55.32M, and earnings per share declined from -$0.837 to -$1.2034.
D
Sell
5/5/2022Upgraded
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index, growth index and volatility index.
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index, growth index and volatility index.
D
Sell
4/20/2022Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index and valuation index.
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index and valuation index.
D
Sell
11/23/2021Upgraded
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
Travere Therapeutics, Inc. (TVTX) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
D
Sell
11/8/2021Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index, solvency index and growth index. Debt to equity increased from 0.67 to 0.74, and the quick ratio declined from 5.52 to 4.99.
Travere Therapeutics, Inc. (TVTX) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index, solvency index and growth index. Debt to equity increased from 0.67 to 0.74, and the quick ratio declined from 5.52 to 4.99.
D
Sell
6/1/2021Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D from D+ on 6/1/2021 due to a decline in the volatility index and total return index.
Travere Therapeutics, Inc. (TVTX) was downgraded to D from D+ on 6/1/2021 due to a decline in the volatility index and total return index.
D
Sell
5/7/2021Upgraded
Travere Therapeutics, Inc. (TVTX) was upgraded to D+ from D on 5/7/2021 due to an increase in the total return index, solvency index and valuation index. The quick ratio increased from 4.26 to 6.48, and debt to equity declined from 1.02 to 0.6.
Travere Therapeutics, Inc. (TVTX) was upgraded to D+ from D on 5/7/2021 due to an increase in the total return index, solvency index and valuation index. The quick ratio increased from 4.26 to 6.48, and debt to equity declined from 1.02 to 0.6.
D
Sell
11/27/2020Downgrade
Travere Therapeutics, Inc. (TVTX) was downgraded to D from D+ on 11/27/2020 due to a decline in the valuation index.
Travere Therapeutics, Inc. (TVTX) was downgraded to D from D+ on 11/27/2020 due to a decline in the valuation index.
D
Sell
11/9/2020Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 11/9/2020 due to a noticeable increase in the growth index, total return index and solvency index. Operating cash flow increased 204.37% from -$6.45M to $6.74M, earnings per share increased from -$0.5823 to -$0.4427, and EBIT increased 23.77% from -$18.83M to -$14.35M.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 11/9/2020 due to a noticeable increase in the growth index, total return index and solvency index. Operating cash flow increased 204.37% from -$6.45M to $6.74M, earnings per share increased from -$0.5823 to -$0.4427, and EBIT increased 23.77% from -$18.83M to -$14.35M.
D
Sell
7/9/2020Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 7/9/2020 due to a decline in the valuation index.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 7/9/2020 due to a decline in the valuation index.
D
Sell
6/24/2020Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 6/24/2020 due to an increase in the volatility index and total return index.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 6/24/2020 due to an increase in the volatility index and total return index.
D
Sell
6/5/2020Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 6/5/2020 due to a decline in the volatility index and total return index.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 6/5/2020 due to a decline in the volatility index and total return index.
D
Sell
5/21/2020Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 5/21/2020 due to a large increase in the growth index. Earnings per share increased from -$0.7049 to $0.0187, EBIT increased 10.29% from -$18.94M to -$16.99M, and total revenue increased 2.32% from $46.69M to $47.77M.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 5/21/2020 due to a large increase in the growth index. Earnings per share increased from -$0.7049 to $0.0187, EBIT increased 10.29% from -$18.94M to -$16.99M, and total revenue increased 2.32% from $46.69M to $47.77M.
D
Sell
3/14/2019Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 3/14/2019 due to a decline in the total return index, solvency index and valuation index.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 3/14/2019 due to a decline in the total return index, solvency index and valuation index.
D
Sell
2/27/2019Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 2/27/2019 due to an increase in the valuation index, growth index and volatility index. Earnings per share increased from -$1.3389 to -$0.1811, EBIT increased 16.86% from -$18.98M to -$15.78M, and operating cash flow increased 8.57% from -$3.9M to -$3.57M.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 2/27/2019 due to an increase in the valuation index, growth index and volatility index. Earnings per share increased from -$1.3389 to -$0.1811, EBIT increased 16.86% from -$18.98M to -$15.78M, and operating cash flow increased 8.57% from -$3.9M to -$3.57M.
D
Sell
9/17/2018Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 9/17/2018 due to a decline in the total return index and valuation index.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 9/17/2018 due to a decline in the total return index and valuation index.
D
Sell
8/30/2018Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 8/30/2018 due to an increase in the total return index.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 8/30/2018 due to an increase in the total return index.
D
Sell
8/15/2018Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 8/15/2018 due to a noticeable decline in the total return index, growth index and solvency index. The quick ratio declined from 4.9 to 2.59, EBIT declined 35.81% from -$14.29M to -$19.4M, and earnings per share declined from -$0.4634 to -$0.5574.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 8/15/2018 due to a noticeable decline in the total return index, growth index and solvency index. The quick ratio declined from 4.9 to 2.59, EBIT declined 35.81% from -$14.29M to -$19.4M, and earnings per share declined from -$0.4634 to -$0.5574.
D
Sell
5/7/2018Downgrade
Retrophin, Inc. (RTRX) was downgraded to D+ from C- on 5/7/2018 due to a decline in the growth index, efficiency index and volatility index. Operating cash flow declined 1,625.29% from -$854 to -$14.73M, EBIT declined 173.5% from -$5.22M to -$14.29M, and total revenue declined 8.88% from $42.18M to $38.43M.
Retrophin, Inc. (RTRX) was downgraded to D+ from C- on 5/7/2018 due to a decline in the growth index, efficiency index and volatility index. Operating cash flow declined 1,625.29% from -$854 to -$14.73M, EBIT declined 173.5% from -$5.22M to -$14.29M, and total revenue declined 8.88% from $42.18M to $38.43M.
C
Hold
3/8/2018Upgraded
Retrophin, Inc. (RTRX) was upgraded to C- from D+ on 3/8/2018 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.4603 to -$0.4385, and total revenue increased 4.55% from $40.34M to $42.18M.
Retrophin, Inc. (RTRX) was upgraded to C- from D+ on 3/8/2018 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.4603 to -$0.4385, and total revenue increased 4.55% from $40.34M to $42.18M.
D
Sell
11/28/2017Downgrade
Retrophin, Inc. (RTRX) was downgraded to D+ from C- on 11/28/2017 due to a large decline in the total return index.
Retrophin, Inc. (RTRX) was downgraded to D+ from C- on 11/28/2017 due to a large decline in the total return index.
C
Hold
11/13/2017Upgraded
Retrophin, Inc. (RTRX) was upgraded to C- from D+ on 11/13/2017 due to a major increase in the total return index, solvency index and growth index. EBIT increased 51.07% from -$10.31M to -$5.05M, operating cash flow increased 4.54% from $5.39M to $5.64M, and total revenue increased 3.97% from $38.8M to $40.34M.
Retrophin, Inc. (RTRX) was upgraded to C- from D+ on 11/13/2017 due to a major increase in the total return index, solvency index and growth index. EBIT increased 51.07% from -$10.31M to -$5.05M, operating cash flow increased 4.54% from $5.39M to $5.64M, and total revenue increased 3.97% from $38.8M to $40.34M.
D
Sell
8/16/2017Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 8/16/2017 due to an increase in the total return index, growth index and volatility index. Operating cash flow increased 294.31% from -$2.78M to $5.39M, total revenue increased 15.41% from $33.62M to $38.8M, and EBIT increased 6.78% from -$11.06M to -$10.31M.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 8/16/2017 due to an increase in the total return index, growth index and volatility index. Operating cash flow increased 294.31% from -$2.78M to $5.39M, total revenue increased 15.41% from $33.62M to $38.8M, and EBIT increased 6.78% from -$11.06M to -$10.31M.
D
Sell
5/25/2017Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 5/25/2017 due to a decline in the total return index, solvency index and volatility index.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 5/25/2017 due to a decline in the total return index, solvency index and volatility index.
D
Sell
5/10/2017Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 5/10/2017 due to a large increase in the efficiency index, total return index and volatility index.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 5/10/2017 due to a large increase in the efficiency index, total return index and volatility index.
D
Sell
11/8/2016Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from C- on 11/8/2016 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 176.9% from -$13.4M to -$37.11M, earnings per share declined from -$0.37 to -$1.0036, and EBIT declined 15.3% from -$8.59M to -$9.9M.
Retrophin, Inc. (RTRX) was downgraded to D from C- on 11/8/2016 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 176.9% from -$13.4M to -$37.11M, earnings per share declined from -$0.37 to -$1.0036, and EBIT declined 15.3% from -$8.59M to -$9.9M.
C
Hold
8/5/2016Downgrade
Retrophin, Inc. (RTRX) was downgraded to C- from C on 8/5/2016 due to a significant decline in the efficiency index and solvency index. Net income declined 219.5% from $11.22M to -$13.4M, the quick ratio declined from 3.54 to 2.97, and total capital declined 1.29% from $363.16M to $358.46M.
Retrophin, Inc. (RTRX) was downgraded to C- from C on 8/5/2016 due to a significant decline in the efficiency index and solvency index. Net income declined 219.5% from $11.22M to -$13.4M, the quick ratio declined from 3.54 to 2.97, and total capital declined 1.29% from $363.16M to $358.46M.
C
Hold
5/6/2016Upgraded
Retrophin, Inc. (RTRX) was upgraded to C from D+ on 5/6/2016 due to a significant increase in the efficiency index, growth index and solvency index. Net income increased 554.27% from -$2.47M to $11.22M, EBIT increased 34.37% from -$8.45M to -$5.55M, and the quick ratio increased from 2.82 to 3.54.
Retrophin, Inc. (RTRX) was upgraded to C from D+ on 5/6/2016 due to a significant increase in the efficiency index, growth index and solvency index. Net income increased 554.27% from -$2.47M to $11.22M, EBIT increased 34.37% from -$8.45M to -$5.55M, and the quick ratio increased from 2.82 to 3.54.
D
Sell
3/11/2016Downgrade
Retrophin, Inc. (RTRX) was downgraded to D+ from B- on 3/11/2016 due to a significant decline in the volatility index, growth index and total return index. Operating cash flow declined 278.38% from $1.43M to -$2.55M, and earnings per share declined from $1.7801 to -$0.0681.
Retrophin, Inc. (RTRX) was downgraded to D+ from B- on 3/11/2016 due to a significant decline in the volatility index, growth index and total return index. Operating cash flow declined 278.38% from $1.43M to -$2.55M, and earnings per share declined from $1.7801 to -$0.0681.
B
Buy
2/22/2016Upgraded
Retrophin, Inc. (RTRX) was upgraded to B- from C+ on 2/22/2016 due to a large increase in the volatility index and valuation index.
Retrophin, Inc. (RTRX) was upgraded to B- from C+ on 2/22/2016 due to a large increase in the volatility index and valuation index.
C
Hold
2/16/2016Upgraded
Retrophin, Inc. (RTRX) was upgraded to C+ from C on 2/16/2016 due to an increase in the volatility index and valuation index.
Retrophin, Inc. (RTRX) was upgraded to C+ from C on 2/16/2016 due to an increase in the volatility index and valuation index.
C
Hold
1/28/2016Downgrade
Retrophin, Inc. (RTRX) was downgraded to C from B- on 1/28/2016 due to a large decline in the volatility index.
Retrophin, Inc. (RTRX) was downgraded to C from B- on 1/28/2016 due to a large decline in the volatility index.
B
Buy
1/20/2016Upgraded
Retrophin, Inc. (RTRX) was upgraded to B- from C on 1/20/2016 due to a noticeable increase in the volatility index, valuation index and efficiency index.
Retrophin, Inc. (RTRX) was upgraded to B- from C on 1/20/2016 due to a noticeable increase in the volatility index, valuation index and efficiency index.
C
Hold
1/7/2016Downgrade
Retrophin, Inc. (RTRX) was downgraded to C from C+ on 1/7/2016 due to a decline in the volatility index.
Retrophin, Inc. (RTRX) was downgraded to C from C+ on 1/7/2016 due to a decline in the volatility index.
C
Hold
12/28/2015Downgrade
Retrophin, Inc. (RTRX) was downgraded to C+ from B- on 12/28/2015 due to a decline in the volatility index.
Retrophin, Inc. (RTRX) was downgraded to C+ from B- on 12/28/2015 due to a decline in the volatility index.
B
Buy
12/24/2015Downgrade
Retrophin, Inc. (RTRX) was downgraded to B- from B on 12/24/2015 due to a substantial decline in the volatility index and valuation index.
Retrophin, Inc. (RTRX) was downgraded to B- from B on 12/24/2015 due to a substantial decline in the volatility index and valuation index.
B
Buy
11/10/2015Upgraded
Retrophin, Inc. (RTRX) was upgraded to B from D on 11/10/2015 due to a significant increase in the valuation index, efficiency index and solvency index. The quick ratio increased from 0.84 to 2.44, debt to equity declined from 0.56 to 0.15, and total capital increased 42.15% from $235.5M to $334.76M.
Retrophin, Inc. (RTRX) was upgraded to B from D on 11/10/2015 due to a significant increase in the valuation index, efficiency index and solvency index. The quick ratio increased from 0.84 to 2.44, debt to equity declined from 0.56 to 0.15, and total capital increased 42.15% from $235.5M to $334.76M.
D
Sell
11/9/2015Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 11/9/2015 due to a decline in the valuation index and volatility index.
Retrophin, Inc. (RTRX) was downgraded to D from D+ on 11/9/2015 due to a decline in the valuation index and volatility index.
D
Sell
10/23/2015Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 10/23/2015 due to an increase in the valuation index and solvency index.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 10/23/2015 due to an increase in the valuation index and solvency index.
D
Sell
8/12/2015Downgrade
Retrophin, Inc. (RTRX) was downgraded to D from C on 8/12/2015 due to a significant decline in the efficiency index, solvency index and valuation index. Net income declined 164.37% from $39.66M to -$25.53M, the quick ratio declined from 1.32 to 0.84, and debt to equity increased from 0.5 to 0.56.
Retrophin, Inc. (RTRX) was downgraded to D from C on 8/12/2015 due to a significant decline in the efficiency index, solvency index and valuation index. Net income declined 164.37% from $39.66M to -$25.53M, the quick ratio declined from 1.32 to 0.84, and debt to equity increased from 0.5 to 0.56.
C
Hold
5/15/2015Upgraded
Retrophin, Inc. (RTRX) was upgraded to C from C- on 5/15/2015 due to a significant increase in the efficiency index, volatility index and total return index. Total capital increased 443.41% from $46.52M to $252.81M.
Retrophin, Inc. (RTRX) was upgraded to C from C- on 5/15/2015 due to a significant increase in the efficiency index, volatility index and total return index. Total capital increased 443.41% from $46.52M to $252.81M.
C
Hold
11/17/2014Upgraded
Retrophin, Inc. (RTRX) was upgraded to C- from D- on 11/17/2014 due to a significant increase in the solvency index and valuation index. Debt to equity declined from 77.63 to -8.18.
Retrophin, Inc. (RTRX) was upgraded to C- from D- on 11/17/2014 due to a significant increase in the solvency index and valuation index. Debt to equity declined from 77.63 to -8.18.
D
Sell
8/15/2014Downgrade
Retrophin, Inc. (RTRX) was downgraded to D- from D+ on 8/15/2014 due to a significant decline in the efficiency index, solvency index and valuation index. Total capital declined 2,141.27% from -$4.11M to $83.88M, and net income declined 112.01% from -$70.63M to $8.48M.
Retrophin, Inc. (RTRX) was downgraded to D- from D+ on 8/15/2014 due to a significant decline in the efficiency index, solvency index and valuation index. Total capital declined 2,141.27% from -$4.11M to $83.88M, and net income declined 112.01% from -$70.63M to $8.48M.
D
Sell
7/1/2014Upgraded
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 7/1/2014 due to a large increase in the volatility index, valuation index and efficiency index. Net income increased 437.72% from -$13.13M to -$70.63M.
Retrophin, Inc. (RTRX) was upgraded to D+ from D on 7/1/2014 due to a large increase in the volatility index, valuation index and efficiency index. Net income increased 437.72% from -$13.13M to -$70.63M.
NASDAQ
04/04/2025 12:55PM Eastern
Quotes delayed
